Final results of a phase 1 trial with soquelitinib (SQL), a selective interleukin-2-inducible T cell kinase (ITK) inhibitor for treatment of relapsed/refractory (R/R) T cell lymphomas (TCL)

  • Miller, Richard; 
  • Wilcox, Ryan; 
  • Reneau, John; 
  • Yannakou, Costas; 
  • Kim, Won Seog; 
  • 외 9명
Citations

WEB OF SCIENCE

2
제목
Final results of a phase 1 trial with soquelitinib (SQL), a selective interleukin-2-inducible T cell kinase (ITK) inhibitor for treatment of relapsed/refractory (R/R) T cell lymphomas (TCL)
저자
Miller, Richard; Wilcox, Ryan; Reneau, John; Yannakou, Costas; Kim, Won Seog; Feldman, Tatyana; Kim, Youn-H; Khodadoust, Michael; Radeski, Dejan; Gasiorowski, Robin; Yoon, Dok Hyun; Song, Yuqin; Hotson, Andrew; Mahabhashyam, Suresh
DOI
10.1182/blood-2025-778
발행일
2025-11-03
유형
Meeting Abstract
저널명
Blood
권
146
페이지
778 ~ 779